Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-022473

Chief Executive Officer sold 2,735 shares at $4.67 ($12,767)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2025-08-18 Sale −2,735 $4.67 $12,767 220,058 D
Open-market sales · 2,735 sh · avg $4.67 · $12,767
Loading xslF345X05/form4-08202025_090813.xml…